chrX-80022439-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001109879.2(TBX22):c.-187C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000468 in 1,068,850 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000047 ( 0 hom. 3 hem. )
Consequence
TBX22
NM_001109879.2 5_prime_UTR_premature_start_codon_gain
NM_001109879.2 5_prime_UTR_premature_start_codon_gain
Scores
16
Clinical Significance
Conservation
PhyloP100: -0.438
Genes affected
TBX22 (HGNC:11600): (T-box transcription factor 22) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. Mutations in this gene have been associated with the inherited X-linked disorder, Cleft palate with ankyloglossia, and it is believed to play a major role in human palatogenesis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.04216045).
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX22 | NM_001109878.2 | c.170C>T | p.Pro57Leu | missense_variant | 2/9 | ENST00000373296.8 | NP_001103348.1 | |
TBX22 | NM_001109879.2 | c.-187C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/9 | NP_001103349.1 | |||
TBX22 | NM_016954.2 | c.170C>T | p.Pro57Leu | missense_variant | 1/8 | NP_058650.1 | ||
TBX22 | NM_001109879.2 | c.-187C>T | 5_prime_UTR_variant | 2/9 | NP_001103349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX22 | ENST00000373296.8 | c.170C>T | p.Pro57Leu | missense_variant | 2/9 | 5 | NM_001109878.2 | ENSP00000362393.3 | ||
TBX22 | ENST00000373294.8 | c.170C>T | p.Pro57Leu | missense_variant | 1/8 | 1 | ENSP00000362390.5 | |||
TBX22 | ENST00000476373.1 | n.291C>T | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
TBX22 | ENST00000626498.2 | n.170C>T | non_coding_transcript_exon_variant | 2/9 | 2 | ENSP00000487527.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD3 exomes AF: 0.0000150 AC: 2AN: 133145Hom.: 0 AF XY: 0.0000237 AC XY: 1AN XY: 42147
GnomAD3 exomes
AF:
AC:
2
AN:
133145
Hom.:
AF XY:
AC XY:
1
AN XY:
42147
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000468 AC: 5AN: 1068850Hom.: 0 Cov.: 30 AF XY: 0.00000865 AC XY: 3AN XY: 346862
GnomAD4 exome
AF:
AC:
5
AN:
1068850
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
346862
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.170C>T (p.P57L) alteration is located in exon 2 (coding exon 1) of the TBX22 gene. This alteration results from a C to T substitution at nucleotide position 170, causing the proline (P) at amino acid position 57 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
FATHMM_MKL
Benign
N
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Loss of glycosylation at P57 (P = 0.0339);Loss of glycosylation at P57 (P = 0.0339);
MVP
MPC
0.16
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at